Cargando…
Ticagrelor-induced life-threatening bleeding via the cyclosporine-mediated drug interaction: A case report
RATIONALE: Ticagrelor has become one of the first-line antiplatelet agents in acute coronary syndrome (ACS) patients recommend by the guideline due to its more potent and predictable antiplatelet effect. However, bleeding is still a severe drug adverse reaction of ticagrelor therapy. We report a fir...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer Health
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5604673/ https://www.ncbi.nlm.nih.gov/pubmed/28906404 http://dx.doi.org/10.1097/MD.0000000000008065 |